Trial Profile
Evaluation for the Efficacy,Tolerability,and Safety of Rasagiline in Levodopa-treated PD Patients With Motor Fluctuations: A Multicenter, Double Blind, Randomized, Placebo-Controlled Group Study (China)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2016
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Chongqing Fortune Pharmaceutical
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2013 Primary endpoint 'Off-time' has been met.
- 07 Jan 2013 New trial record